GVS announced that it has entered into a binding agreement with Ningbo Fuji Medical Technology Co., Ltd., a company controlled by Shanghai Fosun Pharmaceutical (Group)

GVS has acquired the 100% of the share capital of the Italian Group Haemotronic, a leading supplier of advanced filtration solutions for highly critical applications